gene therapy for hematological disorders
gene therapy for hematological disorders
... low-level gene transfer, no clear in vivo
selection with chemotherapy
144 GENE THERAPY FOR HEMATOLOGICAL DISORDERS
restoration of cellular and humoral immunity were documented after gene therapy.
Data ... patient completely lacks the endoge-
nous gene product.
150 GENE THERAPY FOR HEMATOLOGICAL DISORDERS
In a murine allogeneic skin transplantation model, foreign ge...
gene therapy for liver disease
... the therapeutic gene. Alternatively, dif-
ferent viral vectors as well as liposomes can be used for ex vivo gene transfer.
154 GENE THERAPY FOR LIVER DISEASE
For in vivo gene therapy, the therapeutic ... worldwide. For these reasons, the liver has become
an important target organ for gene therapy.
At the same time, certain circumstances make the liver an especially cha...
gene therapy for hiv infection
... retroviral-mediated gene transfer is currently
the optimal gene transfer system available for use in HIV-1 gene therapy. The
PRACTICAL ASPECTS OF GENE THERAPY FOR HIV 281
CHAPTER 11
Gene Therapy for HIV ... MKL, Morgan RA. Gene therapy for acquired immune deficiency
syndrome. AIDS Updates 7:1–14, 1994.
Yu M, Poeschla E, Wong-Staal F. Progress towards gene therap...
nonviral vectors for gene therapy, methods and protocols
... al.
(1999) A novel gene delivery system for genetic manipulation of sinusoidal
)endothelial cells by triplex DNA technology: evaluation of targetability and abil-
ity to stabilize triplex formation. ... acid side chains for a DNA carrier. Bioconjugate Chem. 9, 476–481.
Cationic
_
-Helical Peptides 11
11
From:
Methods in Molecular Medicine, vol. 65: Nonviral Vectors for Gene Therapy...
viral vectors for gene therapy
. herpes simplex virus vectors for
gene therapy in neurological diseases. Q. J. Med. 86(11), 697–702.
21. Latchman, D. S. (1994) Herpes simplex virus vectors for gene therapy. Mol.
Biotechnol.. Type 1-Based Vectors
for Gene Delivery to Human Hematopoietic Stem Cells
Ali Ramezani and Robert G. Hawley 467
26 Semliki Forest Viral Vectors for Gene Transfer
Jarmo Wahlfors and Richard A. Morgan. L....
Báo cáo y học: "Oral Rehydration Therapy for Preoperative Fluid and Electrolyte Management"
... 4. Eligibility standard for oral rehydration therapy
I. Patients eligible for oral rehydration therapy (receiving oral rehydration solution)
1. Those who give an informed consent and have not ... and electrolyte management is usually performed by intravenous
therapy. We investigated the safety and effectiveness of oral rehydration therapy (ORT) for
preoperative fluid and elect...
Báo cáo y học: " WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE"
... vaccination in combination with imatinib therapy for a CML patient. A 51
year-old male with CML in CP, who showed a resistance against imatinib therapy for 2.5 years,
began to be treated with ... Ikegame K, Hosen N, Udaka K, Yasukawa M, Ogawa
H, Kawase I, Sugiyama H: Wilms tumor gene peptide-based
immunotherapy for patients with overt leukemia from
myelodysplastic syndrome (M...
Báo cáo y học: "Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome"
... not yet been obtained in therapy for secondary prevention in
ischemic stroke patients with antiphospholipid syndrome (APS). We therefore compared
single antiplatelet therapy and a combination ...
http://www. medsci. org
16
with APS. We therefore compared single antiplatelet
therapy and a combination of antiplatelet and anti-
coagulation therapy for secondary prevention in
isc...
Từ khóa:
- gene therapy for cardiovascular disorders
- components of cell and gene therapy for neurological disorders
- gene therapy for hematologic disorders human immunodeficiency virus infection and cancer
- towards gene therapy for duchenne muscular dystro
- challenges in gene therapy for cystic fibrosis
- cell therapy for cardiovascular disorders
- cell gene therapy for pvd
- 1α gene therapy for peripheral arterial disease
- adeno associated virus mediated gene therapy for retinal degenerative diseases